---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-000305"
form_type: "8-K"
ticker: "AVXL"
cik: "0001314052"
company_name: "ANAVEX LIFE SCIENCES CORP."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:09:16.189570+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Anavex appoints Dr. Axel Paeger to Board of Directors effective Feb 23, 2026

## Summary
- Dr. Paeger appointed to fill a vacancy on the board, effective February 23, 2026.
- Board determined Paeger is independent under Exchange Act and Nasdaq rules.
- Paeger is CEO of AMEOS Group, Europe's leading healthcare provider with 85 hospitals and 19,300 employees.
- No arrangements or transactions requiring disclosure under Item 404(a) between Paeger and Anavex.
- Paeger brings 30+ years of healthcare leadership; compensation consistent with other non-employee directors.

## SEC filing metadata
- accession: 0001731122-26-000305
- form_type: 8-K
- ticker: AVXL
- cik: 0001314052
- company_name: ANAVEX LIFE SCIENCES CORP.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314052/000173112226000305/0001731122-26-000305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314052/000173112226000305/e7371_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-000305
- JSON: https://secwatch.observer/filing/0001731122-26-000305.json
- Plain text: https://secwatch.observer/filing/0001731122-26-000305.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.